Business
Partial Disposal of Shares in SkinBioTherapeutics
OptiBiotix Health plc has partially disposed of its shareholding in SkinBioTherapeutics plc, selling 7,500,000 ordinary shares for £675,000 in cash. These proceeds will be used for general working capital, extending the company's runway into the first half of 2027. Following this sale, OptiBiotix retains 5,700,000 ordinary shares in SkinBioTherapeutics, representing 2.2% of its total issued share capital. Disclaimer*
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\n \nPartial Disposal of Shareholding in SkinBioTherapeutics\n \nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes announces that it has disposed of 7,500,000 ordinary shares in SkinBioTherapeutics plc (AIM:SBTX) (\"SkinBioTherapeutics\"), generating cash proceeds of £675,000 which will be used for the Company's general working capital purposes and are expected to provide the Company with working capital runway into H1 2027.\n \nFollowing the disposal, the Company's shareholding in SkinBioTherapeutics consists of 5,700,000 ordinary shares, representing 2.2% of the total issued share capital of SkinBioTherapeutics at the date of this announcement.\n \nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\n \n\n\n\n\nFor further information, please contact: OptiBiotix Health plc\n\n\nwww.optibiotix.com\n\n\n\n\nNeil Davidson, Chairman\n\n\n \n\n\n\n\nStephen O'Hara, Chief Executive\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\nCairn Financial Advisers LLP (NOMAD and Broker)\n\n\nTel: 020 7213 0880\n\n\n\n\nLiam Murray / Ludovico Lazzaretti / James Western\n \n\n\n\n\n\n\n\n\n\n\n\n\nAbout OptiBiotix - www.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), OptiBiotix Health has developed a range of technologies and commercialised products which modulate the human microbiome to help prevent and manage human disease. Since the Group's inception it has created a wide range of microbiome-based ingredients and products including prebiotic products like SlimBiome®, WellBiome®, SweetBiotix® and Microbiome Modulators within its core OptiBiotix Health plc (OPTI) business, but also skincare through its holdings in SkinBioTherapeutics PLC (SBTX), and probiotics through ProBiotix Health plc (PBX). These companies create a diverse portfolio technologies and products in an emerging area of healthcare that is of growing interest in consumer markets throughout the world.\nCau...